Gertjan Rasschaert, Allyson Peddle, Sabine Tejpar, Nick West, Jenny Ross, Julie C. Switzky, Ken Edwards, Gabor Kari, Suzanne Griffin, Chiuwa Emily Luk, Daniel N. Cohen, Emily Hammatt, Edmund Moon. "AZUR-4, a phase 2, open label, randomized study of neoadjuvant dostarlimab plus capecitabine plus oxaliplatin (CAPEOX) versus CAPEOX alone in previously untreated T4N0 or stage III mismatch repair proficient/microsatellite stable resectable colon cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps3649